Jul 15 2021



Learn how professor Michel Lisanti and collaborators integrated Inovotion’s technology into

their study to provide evidence that elevated ATP production by mitochondrial ATP synthase is a

new therapeutic target for cancer treatments, particularly for preventing tumor

progression. https://www.nature.com/articles/s41418-021-00788-x#Abs1


If you too are interested in optimizing your preclinical drug discovery with our powerful

in vivo technology platform, please contact us for a free estimate! www.inovotion/contact.com


If you wish to discover more example of Inovotion’s client publications in the best peer

reviewed journals please follow the link : https://www.inovotion.com/publications/publications

All our news

All our webinars